vigabatrin has been researched along with Chronic Kidney Failure in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the pharmacokinetics of vigabatrin in a patient affected with tuberous sclerosis who developed major agitation and aggression, while receiving vigabatrin orally (1." | 3.69 | Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure. ( Chiron, C; Guillonneau, M; Jacqz-Aigrain, E; Loirat, C; Macher, MA; Montes, C; Rey, E, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachmann, D | 1 |
| Ritz, R | 1 |
| Wad, N | 1 |
| Haefeli, WE | 1 |
| Jacqz-Aigrain, E | 1 |
| Guillonneau, M | 1 |
| Rey, E | 1 |
| Macher, MA | 1 |
| Montes, C | 1 |
| Chiron, C | 1 |
| Loirat, C | 1 |
2 other studies available for vigabatrin and Chronic Kidney Failure
| Article | Year |
|---|---|
Vigabatrin dosing during haemodialysis.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Monitoring; Epilepsy, Complex Partial; gamma | 1996 |
Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.
Topics: Adult; Anticonvulsants; Enzyme Inhibitors; gamma-Aminobutyric Acid; Humans; Kidney Failure, Chronic; | 1997 |